Who are 480 Biomedical's investors?

480 Biomedical's investors include Polaris Partners.

How much funding has 480 Biomedical raised?

480 Biomedical has disclosed $184.5M raised across 4 rounds.

Where is 480 Biomedical headquartered?

480 Biomedical is headquartered in Watertown, US.

480 Biomedical

Watertown, US · Delaware corporation · 1 known investors

Founders & leadership

Maria PalasisExecutive

Board

Robert LangerBoard directorScientific Advisory Committee Member at Polaris Partners

Guido NeelsBoard director

Terrance McGuireBoard director

Richard MottBoard director

Carmichael S. RobertsBoard director

Tony SemedoBoard director

Dennis DoughertyBoard director

George WhitesidesBoard director

Investors · 1

Polaris PartnersreportedBoston · $500K – $5M

Reported raises · per SEC filings

Form D private placements

$184.5M disclosed across 4 rounds · 2016–2023

▶$50MraisedJun 2023 · 24 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

W. Bradford SmithDirector
Konstantin PoukalovDirector
Maria Palasis, Ph.D.Executive Officer, Director
James R. TobinDirector
Nancy Snyderman, M.D., FACSDirector
C. Ann MerrifieldDirector
Richard Nieman, M.D.Executive Officer
Harlan Waksal, M.D.Executive Officer, Director
John Bishop, Ph.D.Executive Officer
Jason CavalierExecutive Officer
Michael AltmanDirector
Edward AndersonDirector

Offering amount: $50M
Amount sold: $50M
Sales commissions: $3.1M
Placement agents: William Blair & Company, L.L.C., Cantor Fitzgerald & Co., H.C. Wainwright & Co., LLC
First sale: May 2023
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$100.5MraisedApr 2022 · 34 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Harlan Waksal, M.D.Executive Officer, Director
Jason CavalierExecutive Officer
Maria Palasis, Ph.D.Executive Officer, Director
Michael AltmanDirector
Nancy Snyderman, M.D., FACSDirector
Konstantin PoukalovDirector
Robert Richard, Ph.D.Executive Officer
Pamela NelsonExecutive Officer
Edward AndersonDirector
C. Ann MerrifieldDirector
W. Bradford SmithDirector
Corinne NoyesExecutive Officer
James R. TobinDirector

Offering amount: $100.5M
Amount sold: $100.5M
Sales commissions: $3.8M
Placement agents: MTS Securities, LLC
First sale: Apr 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$28MraisedJan 2020 · 14 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Konstantin PoukalovDirector
Ann MerrifieldDirector
Bradford SmithDirector
George WhitesidesDirector
Maria Palasis, Ph.D.Executive Officer, Director
Robert LangerDirector
Edward AndersonDirector
Don ElseyExecutive Officer
Michael AltmanDirector

Offering amount: $28M
Amount sold: $28M
First sale: Jan 2020
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$6MraisedNov 2016 · 9 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Robert LangerDirector
Guido NeelsDirector
Maria PalasisDirector, Executive Officer
Terrance McGuireDirector
Richard MottDirector
Carmichael S. RobertsDirector
Tony SemedoDirector
George WhitesidesDirector
Dennis DoughertyDirector

Offering amount: $6M
Amount sold: $6M
First sale: Nov 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are 480 Biomedical's investors?: 480 Biomedical's investors include Polaris Partners.
How much funding has 480 Biomedical raised?: 480 Biomedical has disclosed $184.5M raised across 4 rounds.
Where is 480 Biomedical headquartered?: 480 Biomedical is headquartered in Watertown, US.